---

---

Exhibit 10.8

# Advisory Board
Agreement

THIS ADVISORY BOARD AGREEMENT
(Agreement) is dated September 28, 2006 between Acro Inc.,a
corporation with offices at 18 Halevna Street, Timrat, Israel 23840 (the
Company) and Professor K. Barry Sharpless, with an address at TSRI, 10550 N.
Torrey Pines Road, La Jolla, CA 92037 (the Advisor).

NOW THEREFORE THIS AGREEMENT
WITNESSES as follows:

1.1     Appointment of Advisor.
The Company hereby agrees to appoint the Advisor as a member of the Companys
Advisory Board (the Advisory Board) and the Advisor hereby agrees to be a
member of the Advisory Board upon the execution of this Agreement. The Advisor will advise
the Company from time to time on issues as requested by the Company. The Company will
notify the public of the Advisors position. The Advisor will make himself reasonably
available to attend meetings or for conversations to discuss business of the Company at
the Companys request. It is understood that the Advisor is an employee of the
Scripps Research Institute and is bound by its Uniform Consulting Agreement Provisions
which are appended hereto and incorporated by specific reference.

1.2     Restricted Shares. As
compensation for being a member of the Advisory Board pursuant to this Agreement, the
Company agrees to grant 8,333 shares of the Companys common stock (the
Shares) to the Advisor at the end of every financial quarter of the Company in
which the Advisor serves as a member of the Advisory Board, but not more than 100,000
shares.

1.3     Advisors
Acknowledgements. The Advisor acknowledges that the Shares will not be registered
under the laws of any country, including the United States Securities Act of 1933
(the 1933 Act), or under any state securities or blue sky laws of
any state of the United States, and, unless so registered, may not be offered or sold in
the United States or the U.S. Persons, except in accordance with the provisions of
Regulation S under the 1933 act, pursuant to an effective registration statement under the
1933 Act, or pursuant to an exemption from, or in a transaction not subject to, the
registration requirements of the 1933 Act and only in accordance with all applicable
securities laws. United States and U.S. Persons are as defined by
Regulation S under the 1933 Act.

1.4     Expenses. The Company will
reimburse the Advisor for pre-approved expenses necessarily incurred by the Advisor
carrying out his duties.

1.5     Termination. This
Agreement is deemed effective upon execution and will continue in force and effect unless
terminated by either party who shall be entitled, at any time, to terminate this Agreement
upon 30 days written notice delivered to the other party.

1.6     Maintenance of Confidential
Information. The Advisor acknowledges that in the course of his appointment hereunder
the Advisor may have access to Confidential Information. The Advisor acknowledges that
Confidential Information constitutes a proprietary right, which the Company is entitled to
protect. Accordingly, the Advisor covenants and agrees that during the term of this
Agreement and thereafter until such time as all the Confidential Information becomes
publicly known and made generally available through no action or inaction of the Advisor,
the Advisor will keep in strict confidence the Confidential Information and shall not,
without prior written consent of the Company in each instance, disclose, use or otherwise
disseminate the Confidential Information, directly or indirectly, to any third party.



---

---



1.7     Entire Agreement. The
parties hereto agree that they have expressed herein their entire understanding and
agreement concerning the subject matter of this Agreement and it is expressly agreed that
no implied covenant, condition, term or reservation or prior representation or warranty
shall be read into this Agreement relating to or concerning the subject matter hereof or
any matter or operation provided for herein.

IN WITNESS WHEREOF, the parties have
duly executed this Agreement as of the day and year first above written.

|ACRO INC.Per:     /s/ Gadi Aner
Authorized Signatory |  | 
|------------------------------------------------------------------ |  | 

Name: Gadi Aner
Title: Chairman of the Board of Directors

|EXECUTED in the presence of:/s/  Laureen C. Stay
Signature of Witness |  | 
|----------------------------------------------------------------------------------- |  | 

|Laureen C. Stay      
Print Name of Witness | x  /s/ K.  Sharpless
K. Barry Sharpless
|--------------------------------------------------------- | -----------------------------------------------------

The Scripps Research Institute 
Address of Witness10550 N. Torrey Pines Road, La Jolla, CA 92037

Assistant to Dr. Sharpless                                     
Occupation of Witness

2

---

---



THE SCRIPPS RESEARCH
INSTITUTE 
UNIFORM CONSULTING
AGREEMENT PROVISIONS

1.    
          All arrangement and agreements in which a member of the staff of The Scripps
          Research Institute (TSRI) provides consulting services to any profit
          making or commercial organization (hereinafter referred to as a
          Company) shall refer to these Uniform Consulting Agreement
          Provisions (Uniform Provisions) by specific reference and attach
          same to the agreement or include same verbatim in the agreement. If anything in
          an agreement to provide consulting services between Company and a TSRI staff
          member (Consultant) is inconsistent with these Uniform Provisions, these Uniform
          Provisions shall govern. No such agreement shall be of any force or effect
          unless it is subject to these Uniform Provisions and is approved in writing by
          TSRIs Office of Technology Development.

2.    
          TSRI staff members shall spend no more than a total of ten percent of their
          professional effort in consulting services for all Companies. Consulting fees
          shall be paid directly to the Consultant. Such consulting services shall not
          involve any research or laboratory work.

3.    
          Neither the name nor the reputation of TSRI, Scripps Foundation for Medicine and
          Sciences (SFMS) or Scripps Health (SH) shall be
          publicized or exploited directly or indirectly by the Company. Except with
          respect to any filings with the Securities and Exchange Commission or otherwise
          required by law. The Company and the Consultant shall hold TSRI, SFMS and SH and
          their officers, trustees, and employees harmless from all claims, charges,
          damages, and judgments arising from consulting services and shall indemnify
          TSRI, SFMS and SH for costs, direct and indirect, of defending any action
          arising from the consulting agreement or services preformed thereunder. Neither
          the Company nor the Consultant shall use any services, personnel, facilities or
          equipment of TSRI in performing consulting services.

4.    
          Consultants rights, title and interest in inventions, discoveries and
          developments arising from Company funded consulting services made solely or
          jointly with Company employees or agents may be assigned to the Company, so long
          as the provisions in Section 5 below are not applicable.

5.    
          Company shall not obtain any rights in or respecting any invention, discovery or
          development of the Consultant which: (a) was conceived, reduced to practice,
          published, or submitted for publication, by the Consultant before the effective
          date of the consulting agreement, (b) was at any time conceived or reduced to
          practice independent of consulting services performed hereunder, (c) is the
          result of work conducted within TSRI, (d) is subject to Consultants
          obligation to assign to TSRI, and/or (e) relates in any manner to the business
          of TSRI.

6.    
          The Company shall have no rights or interests in any of the inventions,
          discoveries, developments, improvements, or products which may arise from the
          research or other scientific work performed by the Consultant outside the scope
          of the consulting agreement or performed by other scientists of TSRI. Further,
          it is understood that the Consultant shall not disclose to the Company any such
          research or other scientific work to the extent that any such disclosure might
          impair the patent rights or the proprietary rights of TSRI or other third
          parties.

3

---

---



7.    
          In the event of any dispute as to whether TSRI has any rights in an invention
          which Company claims to own, the determination of inventorship, conception,
          and/or reduction to practice shall be determined jointly by patent counsel for
          TSRI and patent counsel for Company, according to the patent laws of the United
          States. In the event such patent counsel cannot mutually agree, then the
          determination shall be by a qualified and independent patent lawyer nominated by
          TSRI and approved by Company, which approval shall be withheld unreasonably. The
          independent patent attorney shall serve as a sole arbitrator, to whom TSRI and
          Company shall submit their proofs and arguments. If Company does not approve the
          appointment of said independent patent lawyer, then Sand Diego County Superior
          Court shall appoint an independent patent lawyer to serve as the arbitrator.
          TSRI and Company shall share equally in paying the costs and fees of the
          independent patent attorney. The arbitrator may interview all persons and review
          all documents which the arbitrator deems necessary or proper to reach a
          determination. Such determination shall be binding upon TSRI and Company;
          excepting only, however, if a different determination is made later by the
          United Sates Patent and Trademark Office or by a United States court in
          proceedings initiated by a third party (other than TSRI or Company), and TSRI
          and Company are given an opportunity to participate in said proceedings, then
          TSRI and Company hereby agree to be bound by said different determination.

8.    
          Nothing in the consulting agreement shall limit or be construed to limit the
          right of Consultant or of TSRI to use or publish information which (a) was in
          the public domain before the consulting services were performed (b) was know to
          Consultant or TSRI, respectively, before the consulting services were performed,
          (c) was developed or acquired independently of the Company or TSRI, or (d)
          becomes public knowledge without breach by Consultant of any obligations of
          confidence to Company or TSRI

9.    
          The Uniform Provisions shall be and hereby are in force for the entire term of
          any consulting agreement between Consultant and Company.

10.    
          Upon termination of consulting services, the Consultant shall, if requested by
          the Company, leave all notes and records of his/her consulting services with
          Company, but shall be entitled to retain one copy thereof for archival purposes,
          subject to any obligations of confidence to Company.

11.    
          If the Company call upon the Consultant to testify in any expert capacity, in
          Court, deposition or otherwise, the Company shall pay the Consultant for all
          time spent in preparing for and giving such testimony at a rate no lower than a
          pro rata fee commensurate with the consulting fee set forth in the consulting
          agreement, adjusted for inflation, and in addition, shall pay lodging, travel
          and other actual costs incurred by the Consultant in connection with such
          testimony.

12.    
          The consulting agreement and these Uniform Provisions shall be construed and
          enforced in accordance with the laws of the State of California and the United
          States patent laws.

4

---

---



|ACCEPTED:
|---------

| |         |                      |                                        
| | ------- | -------------------- | ---------------------------------------
| | Company | By:   
Date: 
Title: | /s/ Gadi AnerSeptember 28, 2006Chairman

| |                    |                               
| | ------------------ | ------------------------------
| | Consultant:
 Date: | /s/ K. Sharpless
July 14, 2006

Contract approved for the Scripps Research Institute, La Jolla, California, this 6th day of July, 2006.

/s/ Jennifer L. Dyer        
Jennifer L. Dyer
Director, Technology Development
The Scripps Research Institute

5

---

---